Bend the Curves

Incremental change—activism that successfully defends or advances critical research or policy—can sometimes feel inconsequential, particularly when it is hard won, resource intensive, and intangible. But in the context of public health strategies with ambitious targets and formidable stakeholder engagement, it is an undeniable facet of progress. In this issue of TAGline, we highlight some important recent successes and challenges in meeting TAG’s overarching goals: moving beyond achingly slow trends and sharply bending the curves on new HIV, hepatitis C, and tuberculosis infections, suffering, and deaths.

In this issue of TAGline:

Bend the Curves: Activism and the Elimination of HIV, HCV, and TB
By Tim Horn

The Usual Suspects: Common Challenges for ETE Planning and Implementation in Emerging Jurisdictions
By Jeremiah Johnson

New York State EtE Campaign Update: Successes & Challenges
By Jeremiah Johnson

The Role of Vaccines and Cures in HIV Elimination
By Richard Jefferys

It’s up to You, New York: Moving towards HCV Elimination in the Empire State
By Annette Gaudino

Global HCV Elimination Targets and Challenges: An Interview with Andrew Hill
By Bryn Gay & Annette Gaudino

From Moscow to New York and Beyond: The Future of Tuberculosis Research and Development
By Safiqa Khimani and Mark Harrington

The United Nations’ Back Yard: TB Elimination in New York State and the U.S.
By Erica Lessem

In a State of Disunion: HIV, TB, and HCV Elimination Policies and Priorities Under the Trump Administration
By Suraj Madoori